Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT00489944
Title Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors San Diego Pacific Oncology & Hematology Associates

uveal melanoma


Cisplatin + Sunitinib + Tamoxifen

Age Groups: adult
Covered Countries USA

No variant requirements are available.